Assessing the potential for AAV vector genotoxicity in a murine model.
about
The gene therapy journey for hemophilia: are we there yet?A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiformeAdeno-associated virus-mediated microRNA delivery and therapeuticsAAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing ActivityLong-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonatesIn vivo genome editing restores haemostasis in a mouse model of haemophiliaLessons Learned from Animal Models of Inherited Bleeding Disorders.Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 SplicingTranslational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogsInfluence of immune responses in gene/stem cell therapies for muscular dystrophies.Vector integration and tumorigenesis.rAAV-mediated tumorigenesis: still unresolved after an AAV assaultPseudotyped AAV vector-mediated gene transfer in a human fetal trachea xenograft model: implications for in utero gene therapy for cystic fibrosis.High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivoEmpty Virions In AAV8 Vector Preparations Reduce Transduction Efficiency And May Cause Total Viral Particle Dose-Limiting Side-EffectsVector design influences hepatic genotoxicity after adeno-associated virus gene therapy.Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challengesHitting the target without pulling the triggerAAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosisIntegration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver.Induction of hepatocellular carcinoma by in vivo gene targeting.GeIST: a pipeline for mapping integrated DNA elementsTelomerase gene therapy: a novel approach to combat agingPatterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicityGenotoxicity in Mice Following AAV Gene Delivery: A Safety Concern for Human Gene Therapy?Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correctionImmune responses to AAV vectors: overcoming barriers to successful gene therapyRecombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and PatientsLow-dose Gene Therapy Reduces the Frequency of Enzyme Replacement Therapy in a Mouse Model of Lysosomal Storage Disease.Gene therapy for haemophilia: a long and winding road.Advancements in adeno-associated viral gene therapy approaches: exploring a new horizon.Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®).Gene delivery in tissue engineering and regenerative medicine.Developments in Viral Vector-Based Vaccines.Progress toward improved therapies for inborn errors of metabolism.Adeno-Associated Virus Gene Therapy for Liver Disease.Short DNA Hairpins Compromise Recombinant Adeno-Associated Virus Genome Homogeneity.Current and future prospects for hemophilia gene therapy.Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models.
P2860
Q26823818-3A88A2B2-34CB-41E8-86EA-95AE8C3ED008Q26849375-DF99F5C3-DB92-4F75-9AF6-EF5918D0341EQ27005597-7A15DAC0-118F-4842-8BE3-7CEE339894C7Q27318266-82EB6A4E-1429-40C1-8756-D8DB3BB98D9FQ27318381-D98B8787-22CB-4BB1-AFD1-D7C5620A30A6Q28241725-55EF7C29-9347-49E1-8DC4-73CC4C9F7739Q30409863-7EBBE65B-4799-443C-9461-F239EEDCDD73Q30828907-EC8D8852-761F-4A82-A91D-D861125923FBQ30891500-90983D90-4203-4C8D-A081-778D3012FEBAQ33736192-6E936AC1-86E2-4897-8782-182144229BE6Q33782783-7B09F321-D65C-4C34-82D7-8EC5F3B945ADQ34310293-D2C99DEE-B473-49B0-8049-4E276E06287DQ34399258-9181966C-4BC8-4211-93EC-03D3744CA065Q34629995-4E9D4183-0442-4EE2-9C59-5FAEBEBEC1F4Q34632510-213028C3-9435-47BD-B967-BDB4D8E6B716Q35056714-96CC3D0E-64C7-4FCD-9F3A-7F2D423FDA22Q35431994-A2FDE9EC-9A6D-4D1E-8480-289F752B9E7EQ35591457-525925D1-1B10-43F8-A967-3882771A56FBQ35988700-762B6E75-AA2F-4C16-B957-5476885C1FC1Q36013060-434AE3DD-77BA-4EBB-898E-F1209BE9A86FQ36014088-5DDA8504-BA9B-4903-B297-F78D61B75BCFQ36094151-55BDC4CD-4E2E-4290-B637-CBE2D76BC909Q36117412-B3B63506-EEE8-4EA8-BC5C-39584A7EC4EAQ36386433-861659CF-DAF4-4007-8528-4A36BA836007Q36401085-F4177C9D-6081-44FF-8AEE-F859EA029FC3Q36756903-99CB43F1-9814-436E-8B07-ED8BF330FC59Q36848708-4E016F99-6BC1-4F1C-80C7-C8D5F19987C7Q36983740-93774CAF-19FF-48E1-976A-B43CF73BB423Q37043497-9B3D0925-DE63-498F-BFA1-131ACBBC6395Q37507816-353188AA-052C-422A-AAFF-0A13AA7FF712Q37903924-C05C7CCA-3209-47D8-86EA-F39074B6E2F2Q37937458-826117E6-6B74-4204-84AC-29F7FD52CD9AQ38168940-74AE790C-6FA6-4D14-A72E-861B9B2190EAQ38306886-AF9A28C1-8A6F-4205-86BC-F6C96ACDB940Q38582090-45AAEA74-640A-4DE1-80EC-92CE936A1CD1Q38601073-531A9BD3-4CE6-432B-8F24-4410253111E3Q38789554-E8293E20-0B50-4D20-9147-50A664743A47Q38809600-A72960AD-6B5F-49E3-9E2F-E767ED16F805Q38827606-6ADEC387-A028-427E-B21B-94523728D8FDQ38907797-B2BDBC7A-BCDC-46D2-A910-364D9D91F001
P2860
Assessing the potential for AAV vector genotoxicity in a murine model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Assessing the potential for AAV vector genotoxicity in a murine model.
@ast
Assessing the potential for AAV vector genotoxicity in a murine model.
@en
Assessing the potential for AAV vector genotoxicity in a murine model.
@nl
type
label
Assessing the potential for AAV vector genotoxicity in a murine model.
@ast
Assessing the potential for AAV vector genotoxicity in a murine model.
@en
Assessing the potential for AAV vector genotoxicity in a murine model.
@nl
prefLabel
Assessing the potential for AAV vector genotoxicity in a murine model.
@ast
Assessing the potential for AAV vector genotoxicity in a murine model.
@en
Assessing the potential for AAV vector genotoxicity in a murine model.
@nl
P2093
P2860
P1433
P1476
Assessing the potential for AAV vector genotoxicity in a murine model.
@en
P2093
Alexander Schlachterman
Federico Mingozzi
Giulio Bussadori
J Fraser Wright
Nirav Malani
Rachel Shah
Shari R Hamilton
Shyrie E Edmonson
Valder R Arruda
P2860
P304
P356
10.1182/BLOOD-2010-08-302729
P407
P577
2010-11-24T00:00:00Z